This resulted in a 4-year event-free and overall survival of 92.1% (95% CI 82.0–100) and 100%, respectively for childhood NUTM1-rearranged ALL (Fig. 1a, b). The gene discussed is NUTM1; the disease is acute lymphoblastic leukemia.